Hagens Berman files securities class action against CVRx following DOJ CID and revenue guidance cut
A federal class action lawsuit was filed against CVRx, Inc. after the company disclosed a U.S. Department of Justice Civil Investigative Demand, a significant revenue guidance cut, sales force deterioration, and a collapse in Medicare Advantage approval rates. The complaint alleges CVRx misled investors about its commercial sales force and reimbursement rates.
Why it matters. CVRx investors with substantial losses are directly affected; the litigation stems from disclosed regulatory and commercial setbacks that triggered a 60% stock price drop and the abrupt termination of the Chief Revenue Officer.